Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation

Hepatocellular carcinoma (HCC) is the third highest cause of cancer death worldwide. In general, the disease is diagnosed at an advanced stage when potentially curative therapies are no longer feasible. For this reason, it is very important to develop new therapeutic approaches. Retinoic acid (RA) is a natural derivative of vitamin A that regulates important biological processes including cell proliferation and differentiation. In vitro studies have shown that RA is effective in inhibiting growth of HCC cells; however, responsiveness to treatment varies among different HCC cell lines. The objective of the present study was to determine if the combined use of RA (0.1 µM) and cAMP (1 mM), an important second messenger, improves the responsiveness of HCC cells to RA treatment. We evaluated the proliferative behavior of an HCC cell line (HTC) and the expression profile of genes related to cancer signaling pathway (ERK and GSK-3β) and liver differentiation (E-cadherin, connexin 26 (Cx26), and Cx32). RA and cAMP were effective in inhibiting the proliferation of HTC cells independently of combined use. However, when a mixture of RA and cAMP was used, the signals concerning the degree of cell differentiation were increased. As demonstrated by Western blot, the treatment increased E-cadherin, Cx26, Cx32 and Ser9-GSK-3β (inactive form) expression while the expression of Cx43, Tyr216-GSK-3β (active form) and phosphorylated ERK decreased. Furthermore, telomerase activity was inhibited along treatment. Taken together, the results showed that the combined use of RA and cAMP is more effective in inducing differentiation of HTC cells.

Saved in:
Bibliographic Details
Main Authors: Ionta,M., Rosa,M.C., Almeida,R.B., Freitas,V.M., Rezende-Teixeira,P., Machado-Santelli,G.M.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2012
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012000800006
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2012000800006
record_format ojs
spelling oai:scielo:S0100-879X20120008000062012-07-31Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiationIonta,M.Rosa,M.C.Almeida,R.B.Freitas,V.M.Rezende-Teixeira,P.Machado-Santelli,G.M. Cell adhesion cAMP Differentiation Proliferation Hepatocarcinoma Retinoic acid Hepatocellular carcinoma (HCC) is the third highest cause of cancer death worldwide. In general, the disease is diagnosed at an advanced stage when potentially curative therapies are no longer feasible. For this reason, it is very important to develop new therapeutic approaches. Retinoic acid (RA) is a natural derivative of vitamin A that regulates important biological processes including cell proliferation and differentiation. In vitro studies have shown that RA is effective in inhibiting growth of HCC cells; however, responsiveness to treatment varies among different HCC cell lines. The objective of the present study was to determine if the combined use of RA (0.1 µM) and cAMP (1 mM), an important second messenger, improves the responsiveness of HCC cells to RA treatment. We evaluated the proliferative behavior of an HCC cell line (HTC) and the expression profile of genes related to cancer signaling pathway (ERK and GSK-3β) and liver differentiation (E-cadherin, connexin 26 (Cx26), and Cx32). RA and cAMP were effective in inhibiting the proliferation of HTC cells independently of combined use. However, when a mixture of RA and cAMP was used, the signals concerning the degree of cell differentiation were increased. As demonstrated by Western blot, the treatment increased E-cadherin, Cx26, Cx32 and Ser9-GSK-3β (inactive form) expression while the expression of Cx43, Tyr216-GSK-3β (active form) and phosphorylated ERK decreased. Furthermore, telomerase activity was inhibited along treatment. Taken together, the results showed that the combined use of RA and cAMP is more effective in inducing differentiation of HTC cells.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.45 n.8 20122012-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012000800006en10.1590/S0100-879X2012007500087
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Ionta,M.
Rosa,M.C.
Almeida,R.B.
Freitas,V.M.
Rezende-Teixeira,P.
Machado-Santelli,G.M.
spellingShingle Ionta,M.
Rosa,M.C.
Almeida,R.B.
Freitas,V.M.
Rezende-Teixeira,P.
Machado-Santelli,G.M.
Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation
author_facet Ionta,M.
Rosa,M.C.
Almeida,R.B.
Freitas,V.M.
Rezende-Teixeira,P.
Machado-Santelli,G.M.
author_sort Ionta,M.
title Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation
title_short Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation
title_full Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation
title_fullStr Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation
title_full_unstemmed Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation
title_sort retinoic acid and camp inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation
description Hepatocellular carcinoma (HCC) is the third highest cause of cancer death worldwide. In general, the disease is diagnosed at an advanced stage when potentially curative therapies are no longer feasible. For this reason, it is very important to develop new therapeutic approaches. Retinoic acid (RA) is a natural derivative of vitamin A that regulates important biological processes including cell proliferation and differentiation. In vitro studies have shown that RA is effective in inhibiting growth of HCC cells; however, responsiveness to treatment varies among different HCC cell lines. The objective of the present study was to determine if the combined use of RA (0.1 µM) and cAMP (1 mM), an important second messenger, improves the responsiveness of HCC cells to RA treatment. We evaluated the proliferative behavior of an HCC cell line (HTC) and the expression profile of genes related to cancer signaling pathway (ERK and GSK-3β) and liver differentiation (E-cadherin, connexin 26 (Cx26), and Cx32). RA and cAMP were effective in inhibiting the proliferation of HTC cells independently of combined use. However, when a mixture of RA and cAMP was used, the signals concerning the degree of cell differentiation were increased. As demonstrated by Western blot, the treatment increased E-cadherin, Cx26, Cx32 and Ser9-GSK-3β (inactive form) expression while the expression of Cx43, Tyr216-GSK-3β (active form) and phosphorylated ERK decreased. Furthermore, telomerase activity was inhibited along treatment. Taken together, the results showed that the combined use of RA and cAMP is more effective in inducing differentiation of HTC cells.
publisher Associação Brasileira de Divulgação Científica
publishDate 2012
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012000800006
work_keys_str_mv AT iontam retinoicacidandcampinhibitrathepatocellularcarcinomacellproliferationandenhancecelldifferentiation
AT rosamc retinoicacidandcampinhibitrathepatocellularcarcinomacellproliferationandenhancecelldifferentiation
AT almeidarb retinoicacidandcampinhibitrathepatocellularcarcinomacellproliferationandenhancecelldifferentiation
AT freitasvm retinoicacidandcampinhibitrathepatocellularcarcinomacellproliferationandenhancecelldifferentiation
AT rezendeteixeirap retinoicacidandcampinhibitrathepatocellularcarcinomacellproliferationandenhancecelldifferentiation
AT machadosantelligm retinoicacidandcampinhibitrathepatocellularcarcinomacellproliferationandenhancecelldifferentiation
_version_ 1756391404737658880